(Total Views: 237)
Posted On: 10/07/2020 11:13:14 AM
Post# of 36557
That is not a trial. They will pay US clinical development required for international markets. I don't read that as US trials which would be tens to hundred million dollars. They would also be setting us up to fail since GNBT/NGIO doesn't have those funds to run US trials...yet.
(0)
(0)
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼
